Table 1 |
|||||||
|
Efficacy at day-28 of sulphadoxine/pyrimethamine (SP) versus amodiaquine (AQ) |
|||||||
|
SP |
AQ |
||||||
|
|
|||||||
|
% |
n |
95% CI |
% |
n |
95% CI |
P value |
|
|
|
|||||||
|
ACPR |
73.9 |
51 |
61.7–83.4 |
54.9 |
39 |
42.7–66.6 |
0.03 |
|
ETF |
2.9 |
2 |
0.5–11.0 |
0 |
0 |
0.0–6.4 |
0.46 |
|
LCF |
1.4 |
1 |
0.2–7.8 |
5.6 |
4 |
1.8–14.5 |
0.38 |
|
LPF |
21.7 |
15 |
13.1–33.6 |
39.4 |
28 |
28.3–51.8 |
0.04 |
|
Failure rate |
|||||||
|
Before PCR-correction |
26.1 |
18/69 |
15.7–36.5 |
45.1 |
32/71 |
33.4–57.3 |
0.02 |
|
After PCR-correction |
11.6 |
8/69 |
5.5–22.1 |
28.2 |
20/71 |
17.7–38.7 |
0.019 |
|
|
|||||||
|
ACPR = adequate clinical and parasitological response; ETF = early treatment failure; LTF = late treatment failure; LCF = late clinical failure; LPF = late parasitological failure |
|||||||
|
Nsimba et al. Malaria Journal 2008 7:31 doi:10.1186/1475-2875-7-31 |
|||||||